Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Arab Journal of Urology|July 31, 2023
Can we offer additional BCG therapy for three-month BCG refractory high grade/T1, Tis bladder cancer patients?Amr A Elsawy, Mahmoud Laymon, Islam Mansour, et al.
Urologic Oncology|August 18, 2020
Prospective Validation of Clinical Usefulness of a Novel mRNA-based Urine Test (Xpert® Bladder Cancer Monitor) for surveillance in Non Muscle Invasive Bladder CancerAmr A Elsawy, Amira Awadalla, Asmaa Elsayed, et al.
Urologic Oncology|March 31, 2021
Can repeat biopsy be skipped after initial complete resection of T1 bladder cancer? The role of a novel urinary mRNA biomarkerAmr A Elsawy, Amira Awadalla, Muhammed Abdullateef, et al.
Urolithiasis|April 28, 2018
Long-term effects of anatrophic nephrolithotomy on selective renal functionAhmed R El-Nahas, Amr A Elsawy, Ahmed Abdelhalim, et al.
Urologic Oncology|November 19, 2018
The value of immediate postoperative intravesical epirubicin instillation as an adjunct to standard adjuvant treatment in intermediate and high-risk non-muscle-invasive bladder cancer: A preliminary results of randomized controlled trialAmr A Elsawy, Ahmed M El-Assmy, Mahmoud A Bazeed, et al.
Urologic Oncology|July 14, 2020
Diagnostic performance and predictive capacity of early urine cytology after transurethral resection of nonmuscle invasive bladder cancer: A prospective studyAmr A Elsawy, Ahmed M Harraz, Fady K Ghobrial, et al.
Clinical Genitourinary Cancer|January 9, 2022
Oncologic Outcomes of Squamous Cell Carcinoma Versus Urothelial Carcinoma With Squamous Differentiation After Radical Cystectomy for Bladder CarcinomaMahmoud Laymon, Ahmed Mosbah, Abdelwahab Hashem, et al.
Urologic Oncology|February 14, 2026
Optimal adjuvant intravesical therapy for intermediate risk non-muscle invasive bladder cancer; oncological and patient-reported outcomes of randomized controlled trialAmr A Elsawy, Mahmoud Laymon, Osama Ezzat, et al.
The Journal of Urology|September 16, 2018
Can We Predict the Outcome of Oral Dissolution Therapy for Radiolucent Renal Calculi? A Prospective StudyAmr A Elsawy, Ahmed M Elshal, Ahmed R El-Nahas, et al.
Minerva Urology and Nephrology|June 22, 2021
Predictors and survival benefit of achieving pentafecta in a contemporary series of open radical cystectomyMahmoud Laymon, Ahmed Mosbah, Abdewahab Hashem, et al.
Pageof 2